Yaman, U. Et Al. 2020. Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.25, no.10 , 1192-1203.

Yaman, U., Aslan, M., ÖZTÜRK, Ş., ULUBAYRAM, K., & EROĞLU, İ., (2020). Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.25, no.10, 1192-1203.

Yaman, Umran Et Al. "Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line," PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.25, no.10, 1192-1203, 2020

Yaman, Umran Et Al. "Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line." PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.25, no.10, pp.1192-1203, 2020

Yaman, U. Et Al. (2020) . "Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line." PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.25, no.10, pp.1192-1203.

@article{article, author={Umran Yaman Et Al. }, title={Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line}, journal={PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY}, year=2020, pages={1192-1203} }